NDC 65250-133 – Exparel
Bupivacaine 13.3 mg/mL · Injection, Suspension, Liposomal · Infiltration
Product NDC65250-133
Product details
- Brand name
- Exparel
- Generic name
- Bupivacaine
- Labeler
- Pacira Pharmaceuticals, Inc.
- Dosage form
- Injection, Suspension, Liposomal
- Route
- Infiltration
- Marketing category
- NDA · NDA022496
- Marketed since
- January 1, 2016
- Listing expires
- December 31, 2026
- Pharmacologic class
- Amide Local Anesthetic
Active ingredients
- Bupivacaine 13.3 mg/mL
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 65250-133-04 | 4 VIAL in 1 CARTON (65250-133-04) / 10 mL in 1 VIAL (65250-133-10) | Sep 2, 2016 |
| 65250-133-09 | 10 VIAL in 1 CARTON (65250-133-09) / 10 mL in 1 VIAL (65250-133-10) | Sep 2, 2016 |
Recalls mentioning this NDC
- D-0621-2020 Dec 11, 2019 · Class II
Sub Potent Drug: Out of Specification (OOS)
Other Exparel products
- 65250-266 Bupivacaine 13.3 mg/mL · Injection, Suspension, Liposomal · Pacira Pharmaceuticals, Inc.